This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. NxStage Medical next reports earnings on July 21, 2014.
To receive a free e-mail notification whenever NxStage Medical makes a similar move, sign up!